Replies to post #216887 on Avid Bioservices Inc (CDMO)

[mmignot]

I'm under the impression that Opdivo Phase III trial is for squamous NSCLC. If this is the case, how would FDA approval of Opdivo affect approval of Bavi, which is for non-squamous treatment?

TIA